Andrew Sungmin Lee, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 3460 E La Palma Ave, Anaheim, CA 92806 Phone: 714-279-4000 |
Orangeview Physical Therapy Inc. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3111 W Orange Ave Ste 130, Anaheim, CA 92804 Phone: 714-229-1900 |
Kirsten Perry, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 5475 E La Palma Ave, Suite 200, Anaheim, CA 92807 Phone: 714-714-0479 Fax: 714-701-7146 |
Luz Lontoc Physical Therapy, Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1007 W La Palma Ave, Suite #4, Anaheim, CA 92801 Phone: 562-682-7442 Fax: 562-596-0476 |
Heidi Bender, DPT Physical Therapist - Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 217 W Cerritos Ave, Anaheim, CA 92805 Phone: 714-776-1231 |
News Archive
This week, Africa seizes an unprecedented chance to drive out polio when 15 countries across the continent launch a synchronized mass immunization campaign to reach 72 million children, capitalizing on gains made this year. A total of some 290 000 vaccinators have been mobilized to go door-to-door to deliver two drops of oral polio vaccine (OPV) to every child under five in areas considered at "highest risk" of polio transmission.
Young adults who are educated about dietary supplements in college are more likely to use them appropriately, according to new research from Binghamton University, State University at New York.
Aspirin therapy's ability to reduce the risk of colorectal cancer, an association seen in a large number of studies, appears to depend on the drug's inhibition of the COX-2 enzyme, the action that also underlies aspirin's usefulness for treating pain and inflammation.
Allergan, Inc. today announced operating results for the quarter ended September 30, 2010. Allergan also announced that its Board of Directors has declared a third quarter dividend of $0.05 per share, payable on December 1, 2010 to stockholders of record on November 10, 2010.
Pharmaceutical company Merck on Friday said that it will begin registering the antiretroviral drug Atripla in developing countries and that it will lower the cost of the drug in countries with high HIV prevalence, the Bergen Record reports.
› Verified 8 days ago